Back to Nuveen, LLC Nuveen, LLC

CADLCADL
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in CANDEL THERAPEUTICS INC

Nuveen, LLC holds 142,978 shares of CADL (CANDEL THERAPEUTICS INC), worth $1.5M as of 2026-Q2. The position was increased (+53.5% shares). CADL represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$1.5M

Current Shares

142,978

Total Value Change

+$1M

Total Shares Change

+64,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
142,978
+53.5%
$1.5M0.0%$10.30
36
2026-Q1
Increased
93,158
+0.7%
$456,4740.0%$4.91
24
2025-Q4
Decreased
92,482
-55.9%
$522,5230.0%$5.71
0
2025-Q3
Increased
209,662
+126.7%
$1.1M0.0%$5.40
41
2025-Q2
Increased
92,482
+18.4%
$467,9590.0%$4.90
28
2025-Q1
New
78,145
-
$441,5190.0%$5.95
33

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used